Coronavirus - Niger: United States Donates Second Batch of 151,200 COVID-19 Vaccines to Niger

U.S. Embassy in Niger

U.S. Embassy in Niger

The U.S. Embassy in Niamey, Niger announces the donation by the United States Government of a second batch of 151,200 doses of the single shot Johnson&Johnson COVID-19 vaccine as part of the Biden-Harris Administration’s global efforts to fight the COVID-19 pandemic.  In the past week, the Embassy donated 151,200 vaccines from the American people to the people of Niger.  The U.S. government coordinated closely with the African Union, Africa CDC, and COVAX on the country allocations.  COVAX supported delivery of these vaccine doses, which arrived in Niamey on July 29, 2021. 

This donation will help protect the Nigerien people from the ravages of the COVID-19 virus and begin reducing barriers to building back Niger’s economy.  “Today, the United States is using the power of its democracy, the ingenuity of American scientists, and the force of American manufacturing to beat the pandemic on a global scale,” explained Ambassador Eric Whitaker. 

This combined total of 302,400 doses is part of the Biden-Harris Administration commitment to share U.S. vaccine supply with the world.  As we continue to fight the COVID-19 pandemic at home and work to end the pandemic worldwide, President Biden has promised that the United States will be an arsenal of vaccines. 

The U.S. government, through USAID Niger, is also supporting the Ministry of Health’s work to ensure Niger can safely and effectively distribute these vaccines.  USAID is providing assistance to support training, planning, supply chain logistics, and communications outreach to make certain the vaccines are available for the people of Niger.

Distributed by APO Group on behalf of U.S. Embassy in Niger.

Send us your press releases to

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases